PT1127133E - Polipeptido que proporciona permeabilidade celular - Google Patents

Polipeptido que proporciona permeabilidade celular

Info

Publication number
PT1127133E
PT1127133E PT99963187T PT99963187T PT1127133E PT 1127133 E PT1127133 E PT 1127133E PT 99963187 T PT99963187 T PT 99963187T PT 99963187 T PT99963187 T PT 99963187T PT 1127133 E PT1127133 E PT 1127133E
Authority
PT
Portugal
Prior art keywords
cell permeability
polypeptide
polipeptido
provides cell
substances
Prior art date
Application number
PT99963187T
Other languages
English (en)
Inventor
Hildt Eberhard
Schmidt Stephanie
Original Assignee
Island Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Island Pharmaceuticals Ltd filed Critical Island Pharmaceuticals Ltd
Publication of PT1127133E publication Critical patent/PT1127133E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT99963187T 1998-11-03 1999-11-03 Polipeptido que proporciona permeabilidade celular PT1127133E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19850718A DE19850718C1 (de) 1998-11-03 1998-11-03 Zellpermeabilität-vermittelndes Polypeptid

Publications (1)

Publication Number Publication Date
PT1127133E true PT1127133E (pt) 2005-05-31

Family

ID=7886584

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99963187T PT1127133E (pt) 1998-11-03 1999-11-03 Polipeptido que proporciona permeabilidade celular

Country Status (9)

Country Link
US (1) US7262267B1 (pt)
EP (1) EP1127133B1 (pt)
JP (1) JP2002528120A (pt)
AT (1) ATE287956T1 (pt)
AU (1) AU1962400A (pt)
DE (2) DE19850718C1 (pt)
ES (1) ES2237194T3 (pt)
PT (1) PT1127133E (pt)
WO (1) WO2000026379A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6986613B2 (en) 1997-07-15 2006-01-17 Silverbrook Research Pty Ltd Keyboard
DE19904800C1 (de) * 1999-02-05 2001-02-08 Eberhard Hildt Partikel zur Gentherapie
DE10240894A1 (de) * 2002-09-04 2004-03-11 Procom Biotechnologische Produktions Gmbh Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut
BR112014031891A2 (pt) 2012-06-19 2017-08-01 Univ Minnesota direcionamento genético nas plantas utilizando vírus de dna
CN105531372A (zh) 2013-06-14 2016-04-27 塞尔克蒂斯股份有限公司 植物中非转基因基因组编辑方法
EP3059242A4 (en) * 2013-10-17 2017-04-19 Seoul National University R&DB Foundation Alpha helix cell-penetrating peptide multimer, preparation method therefor and use thereof
JP2018529689A (ja) * 2015-09-17 2018-10-11 ソウル大学校産学協力団Ｓｅｏｕｌ Ｎａｔｉｏｎａｌ Ｕｎｉｖｅｒｓｉｔｙ Ｒ＆Ｄｂ Ｆｏｕｎｄａｔｉｏｎ グラム陰性菌に対する抗菌活性を示す切断または折り畳まれたヘリックスペプチドまたはペプチド類似体およびその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2041772A1 (en) * 1990-05-11 1991-11-12 Larry T. Mimms Monoclonal antibodies to pres2 and pres1 polypeptide of the hepatitis b viral envelope
CA2180726A1 (en) * 1994-01-27 1995-08-03 Evgeni Veniaminovic Sokurenko Receptor specific bacterial adhesins and their use
DE19808258A1 (de) * 1997-02-28 1998-09-03 Evotec Biosystems Gmbh Kopfaktivator-bindendes Protein oder Polypeptid und Verfahren zur Suche nach funktionalen Agonisten oder Antagonisten unter Verwendung von kopfaktivatorbindendem Protein oder Polypeptid
AU754938B2 (en) * 1997-05-06 2002-11-28 Boehringer Ingelheim Vetmedica Gmbh PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays
DE19904800C1 (de) 1999-02-05 2001-02-08 Eberhard Hildt Partikel zur Gentherapie

Also Published As

Publication number Publication date
ATE287956T1 (de) 2005-02-15
ES2237194T3 (es) 2005-07-16
EP1127133B1 (de) 2005-01-26
US7262267B1 (en) 2007-08-28
DE59911530D1 (de) 2005-03-03
DE19850718C1 (de) 2000-05-18
EP1127133A2 (de) 2001-08-29
WO2000026379A2 (de) 2000-05-11
JP2002528120A (ja) 2002-09-03
WO2000026379A3 (de) 2000-10-05
AU1962400A (en) 2000-05-22

Similar Documents

Publication Publication Date Title
DE69534235D1 (de) Cytokin lerk-7
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
ID24377A (id) Senyawa hidrogen anorganik, metoda pemisahan dan penerapannya untuk bahan bakar
BR9810654B8 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
ATE469911T1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE255420T1 (de) Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
HK1040401A1 (en) Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof
TR200100056T2 (tr) Nörotrofik faktörler
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DE69836126D1 (de) Verfahren zur einbringung einer funktionalität
PT1127133E (pt) Polipeptido que proporciona permeabilidade celular
DK1179183T3 (da) Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr
ATE237870T1 (de) Kompositmembran
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
DK0750637T3 (da) CAI resistens, som koder for et protein, samt anvendelse deraf
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
PE20399A1 (es) Muteina ob
DE59611293D1 (de) Protein mit dnase-aktivität
NZ334744A (en) Method for determining expression of aberrant forms of APC protein
WO1998030687A3 (de) Srcr domäne-enthaltendes protein
ATE329035T1 (de) Cytoplasmische tyrosin kinase
IT1302941B1 (it) Serbatoio di carburante per motocicli e procedimento per la suaproduzione.
DE59611353D1 (de) Transketolase-verwandtes protein
ATE283358T1 (de) Protease-ähnliches protein